Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
The dextrose component provides osmotic pressure for peritoneal dialysis, promoting ultrafiltration of fluid and removal of solutes. Calcium and other electrolytes maintain physiologic balance.
Dianeal PD-2 with Dextrose 1.5% is a peritoneal dialysis solution. Dextrose acts as an osmotic agent to create an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (urea, creatinine) and excess fluid from the blood into the peritoneal cavity, which is then drained out.
Intraperitoneal: Continuous ambulatory peritoneal dialysis (CAPD): 2-2.5 L per exchange, 4-5 exchanges per day; Continuous cyclic peritoneal dialysis (CCPD): 2-2.5 L per exchange, 3-5 nocturnal exchanges plus one daytime dwell.
Intraperitoneal: 2-2.5 L per exchange, 4 exchanges per day (continuous ambulatory peritoneal dialysis).
None Documented
None Documented
Not applicable as a solution; glucose half-life ~20-30 min in circulation; clinical effect duration corresponds to dwell time (4-6 hours for standard exchange)
Not applicable; dextrose utilization is capacity-limited with half-life of ~1.5 hours in normal circulation. In peritoneal dialysis, the osmotic effect declines over dwell time (2-4 hours) as dextrose is absorbed.
Primarily eliminated via peritoneal dialysis; glucose is metabolized systemically and excreted as CO2 and water; <5% renal excretion of metabolites
Dextrose is completely metabolized via glycolysis and the citric acid cycle to carbon dioxide and water; <1% excreted unchanged in urine. Osmotic agent effect terminated by peritoneal absorption and systemic metabolism.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution